CRISPR THERAPEUTICS AG (CRSP) Stock buybacks
CRISPR THERAPEUTICS AG (CRSP) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$57,000FY2020
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $57,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CRSP financial trends
CRSP RevenueCRSP Net incomeCRSP Net marginCRSP Gross profitCRSP Gross marginCRSP Operating incomeCRSP Operating marginCRSP Operating cash flowCRSP Free cash flowCRSP Capital expendituresCRSP Return on equityCRSP Dividends paidCRSP Total assetsCRSP Total liabilitiesCRSP Shareholders’ equityCRSP overview →